Beautiful Virgin Islands

Monday, Jul 14, 2025

Scientists develop antibiotics against superbugs

Hong Kong scientists make major breakthrough in neutralizing drug-resistant superbugs.

Scientists in Hong Kong claim to have made a major medical breakthrough by developing a new family of antibiotics powerful enough to neutralize the superbugs that have spread worldwide and have been almost impossible to treat.

Bacteriologists at a university in Hong Kong claim they have developed a family of antibiotics powerful enough to neutralize multi-drug resistant superbugs, including methicillin-resistant Staphylococcus aureus, or MRSA.

MRSA refers to a group of genetically distinct bacteria pervasive in hospitals, nursing homes and even inside trains and buses in cities worldwide causing several difficult-to-treat infections.

There has been a decades-long global effort to fight MRSA and the search for new antibiotics to stem its spread has shown no progress since the superbugs’ emergence as early as the mid-1980s. People with open wounds or weakened immune systems are at greater risks of infection.

Bacterial drug resistance – public spaces and healthcare centers across the globe are now crawling with superbugs like MRSA – has been declared one of the biggest public health threats by World Health Organization Director-General Margaret Chan, who also served as Hong Kong’s public health chief.

In 2018, Hong Kong reported 1,218 cases of community-associated MRSA infections, a seven-fold jump compared with 2007, the year the first case was found in the city.

Researchers at the Hong Kong Polytechnic University (PolyU) said at a recent press conference that the novel small molecules they had just developed, based on new chemical structure and an antimicrobial mechanism, would be different from those of existing antibiotics incapable of sterilizing items with MRSA.

They claimed their new drug candidates demonstrated effective capabilities of inhibiting bacterial growth with no toxicity to human cells or tissues in numerous lab experiments.

The development and trial of the new class of antimicrobial agents, by PolyU’s Department of Applied Biology and Chemical Technology in partnership with the Chinese University of Hong Kong, is a potential breakthrough in the battle against MRSA.

“Our research is now at the end animal studies, conducting infectious model and pharmacokinetic observation and studies. These are the critical steps preceding clinical trials on humans for drug development,” said Dr Ma Cong, head of the research team.

“As a matter of fact, there are very few antibiotic-related studies among our peers abroad that are able to complete such a stage. Our findings so far are very promising … We believe further studies on these novel compounds will contribute to a new era of antibiotic discovery, contributing towards the fight against superbugs.”

Most antibiotics now in use function through disrupting the DNA synthesis or protein functions of harmful bacteria, while the new drug focuses on preventing the interaction between two proteins, NusB and NusE, which is crucial for synthesis of bacterial ribosomal ribonucleic acid and in turn bacterial cell proliferation.

The team developed a model based on the structure of the two proteins, and applied computer-aided screening to detect about 5,000 small molecule compounds with drug-like properties to act as inhibitors against protein interaction.

Some shortlisted compounds were then put to tests for antimicrobial effectiveness against different MRSA strains.

Test of the compounds on human lung and skin cells infected with MRSA indicated no significant toxicity. The fact that the two proteins exist only in bacteria and not in human cells has already addressed the toxicity concern, according to Dr Ma.

The research team has further structurally modified the compounds for optimization and named them “Nusbiarylins,” based on their target protein “NusB” and their “biaryl” structure.

Lab tests of Nusbiarylins against a panel of MRSA strains proved their consistent antibacterial effectiveness, much better than commonly used antibiotics including vancomycin, which is administered as the “last resort” antibiotic drug against superbugs in many Western countries.

Further pre-clinical studies on the in-vitro pharmacological properties of Nusbiarylins on human cells indicated that the compounds would not result in human blood cell breaking, an indication of being safe for injection, as well as excellent results in intestine absorption, meaning it is effective for oral taking.

The PolyU team won the “Global Innovation Award” at the TechConnect World Innovation Conference and Expo 2019 held in June in the United States.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
Azerbaijan and Armenia are on the brink of a historic peace deal.
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Weinstein Victim’s Lawyer Says MeToo Movement Still Strong
U.S. Enacts Sweeping Tax and Spending Legislation Amid Trade Policy Shifts
Football Mourns as Diogo Jota and Brother André Silva Laid to Rest in Portugal
×